SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (487)2/3/2003 7:01:15 AM
From: Icebrg  Read Replies (1) of 1022
 
Abgenix and Chugai Collaborate to Develop and Manufacture Antibody Therapeutics

Message 18527450

It seems as if Abgenix got a good partner here.

Apart from that, these types of deals demonstrates how focus is shifted towards targeting and away from the method for the development of the mAbs.

One would have thought that Abgenix through their extensive target-harvesting collaborations with among others Curagen and Lexicon would not have to travel to Japan to find promising new anti-body targets to work on.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext